BEAT - HeartBeam rises 10% on LIVMOR team up for cloud-based remote monitoring portal

HeartBeam (NASDAQ:BEAT) is collaborating with LIVMOR to build a HeartBeam branded version of LIVMOR’s Halo+ FDA cleared turnkey solution for remote patient monitoring (RPM) to connect physicians and patients. Under the terms of the agreement, LIVMOR will develop  a HeartBeam branded version, the HeartBeam Platform, of the LIVMOR RPM platform customized for HeartBeam products, with senior executives of both companies supervising the project. “Utilizing LIVMOR's FDA cleared RPM platform will allow us to meet our schedule for FDA submission of our first product, an easy-to-use heart attack detection software solution for Emergency Department settings,” said HeartBeam Founder and CEO Branislav Vajdic. BEAT +9.76% to $2.25 after-hours

For further details see:

HeartBeam rises 10% on LIVMOR team up for cloud-based remote monitoring portal